Rothe Development, Inc. S-1/Aamended IPO prospectus

Executive Summary

Rothe Development sells engineering, mission operations, technology and calibration services, principally to NASA and other federal customers, earning revenue mainly through reimbursable-cost contracts plus fees. Management wants to extend its NASA expertise into commercial space, national security, digital infrastructure and higher-margin calibration services, but commercial revenue remains small. Annual growth reversed into contraction in 9M 2026, profitability approached zero and customer collections consumed cash. The IPO remains unpriced, preventing valuation or buyer-stake calculations; investors would fund both the business and a payment to its controlling CEO, while betting that contract wins and diversification can improve thin margins.

Business Model and Growth Drivers

Government contract funding, renewals and execution dominate results. Government Services generated $123M of FY2025 revenue, up from $113M; cost-plus-fee contracts supplied 93% of total revenue. These reimburse allowable costs plus a fee, limiting both cost risk and profit upside. The five largest customers supplied more than 93% of revenue, while consolidated joint ventures generated $99.9M, making partners nearly as important as Rothe’s own operations.

Rothe operates NASA’s Neutral Buoyancy Laboratory, where astronauts train for spacewalks and simulate missions supporting the International Space Station and Artemis. Other services include engineering, ground systems, mission communications, cybersecurity and information technology. Its accredited calibration laboratories serve regulated commercial customers. Competitive advantages are institutional knowledge, specialized personnel and longstanding customer relationships rather than patents; it competes against both smaller contractors and large aerospace firms.

Commercial Services generated only $3.82M in FY2025. Management’s diversification plans therefore represent opportunities rather than an established growth engine. Backlog was ≈$635M at 9/30/2026, including contract options; it is potential revenue, not guaranteed funding or cash. ROAR’s NASA SEWP VI awards provide a ten-year ordering opportunity, but actual task orders determine their value.

The Offering

• Size and valuation: This preliminary offering leaves price, range, shares and proceeds blank, so implied market capitalization, revenue multiples and IPO buyers’ stakes cannot be calculated on either outstanding or fully diluted bases. Before the IPO, 32.6M common shares were outstanding across both classes. Fully diluted calculations must include underwriter warrants and promised director awards once quantified; ungranted plan reserves are excluded, and Class A conversion does not create additional economic shares.
• Structure: Rothe is offering Class B shares; no secondary selling-stockholder tranche is identified. Titan Partners Securities is sole bookrunner. Its discount is 7%, plus a 0.25% allowance and accountable expenses up to $0.150M. A 30-day over-allotment option covers 15% of shares sold. Nasdaq listing under RDEV is a closing condition.
• Proceeds: ≈$2.4M goes exclusively to CEO Karen Wheeler-Hall to repay her acquisition seller note and related taxes—not company borrowing. Class B buyers receive none. Remaining proceeds fund working capital and general purposes; management also discusses reducing debt, without allocating an amount.
• Capitalization and dilution: Closing reclassifies a $2.62M subscription liability into equity, while $1.89M of deferred offering costs and the CEO distribution reduce equity. Offering proceeds add cash and equity. After-IPO capitalization and tangible assets backing each purchased share remain unquantifiable.
• Share supply: Underwriter warrants cover 6% of shares sold, including over-allotments, at 120% of the IPO price for five years. Existing holders generally face 180-day lock-ups after closing, subject to early release and resale restrictions.

Key Financial Highlights

Amounts in $M; results are historical. Net income labels distinguish Rothe shareholders from joint-venture minority owners.

• Contract economics: Unfavorable estimate revisions increased to $1.35M from $0.359M in FY2025; corporate overhead rose $1.94M with IPO preparation and staffing. These outweighed expanded NASA scope.
• Interim contraction: Government Services revenue fell $5.49M as eMITS funding declined and FOMMS and SEAM ended, explaining nearly all the revenue decline.
• Profit quality: FY2025 benefited from $1.69M of employee retention credits despite its operating loss. The prior interim included $1.17M; their absence and higher interest explain why net earnings deteriorated more than operating profit.
• Collections and liquidity: Receivables reached $23.1M as billing outpaced collections. The $8.0M secured Truist revolver had $2.99M available but matures 6/10/2027. Management expects twelve-month funding coverage; delayed collections could challenge that assessment.

Governance and Control

• Wheeler-Hall owns every Class A share, carrying five votes each versus one for Class B, and is expected to retain majority voting control. Transfers need not eliminate those enhanced votes.
• Rothe qualifies as controlled but currently intends independent board and committee majorities. Wheeler-Hall and President Thomas Hall are married, concentrating leadership within one family.
• The equity and employee purchase plans reserve 15.0M shares, with annual increases. These are future issuance capacity, not outstanding awards.
• Related-party headquarters rent was ≈$0.414M in FY2025; Rothe also guarantees the family landlord’s $2.08M construction loan, creating exposure beyond ordinary rent.

Risk Assessment

• Financial controls: A material weakness covers government revenue estimates, joint-venture reconciliations and classifications; remediation following the new finance chief’s appointment remains unproven.
• Funding deadlines: Cash consumption, the revolver maturity and a $2.28M private-placement repurchase obligation if the IPO misses 1/31/2027 create competing liquidity demands.
• NASA concentration: Reduced task funding or canceled programs could remove revenue and access to government facilities; backlog does not prevent cancellations.
• Contract and partner execution: Thin fees leave little cushion against estimate errors, compliance findings or joint-venture disputes; the expired mentor-protégé relationship may restrict future set-aside opportunities.
• Key executives: Losing Wheeler-Hall or Hall could disrupt customer relationships and operational knowledge that are difficult to replace.
• Control and dilution: Family voting control, the exclusive CEO distribution and expanding equity reserves limit minority influence and can dilute economic ownership.

What to Watch

• NASA awards: Government revenue is contracting; funded renewals and new task orders would validate backlog, while further completions without replacements would weaken it.
• Commercial diversification: Calibration remains small and staff attrition constrained interim capacity; sustained customer growth and laboratory utilization would support management’s strategy.
• Collections and refinancing: Negative interim FCF makes receivable conversion and renewal of the Truist facility decisive; persistent cash consumption would increase financing dependence.
• Final IPO terms: Price, proceeds and fully diluted ownership must establish whether sufficient business funding remains after fees and the CEO payment.